The effect of PLK1 inhibitor in osimertinib resistant non-small cell lung carcinoma cells. [PDF]
Dai X+6 more
europepmc +1 more source
A single-center retrospective study of pathogen distribution and antibiotic resistance of bloodstream infections in emergency department. [PDF]
Tang Y+6 more
europepmc +1 more source
[Research on the clinical characteristics and prognosis of children with chronic myeloid leukemia in the blast phase]. [PDF]
Zheng FY+6 more
europepmc +1 more source
[Advances of Neoadjuvant Targeted Therapy in ALK-positive Non-small Cell Lung Cancer]. [PDF]
Sun W, Zhou Y, Lin Y, Feng S, Long H.
europepmc +1 more source
[Clinical and drug sensitivity characteristics of invasive non-typhoidal <i>Salmonella</i> enteritis in children aged 0-6 years in Chengdu, China, 2022-2023]. [PDF]
Yang LR, Zhou CT, Guo J, Wu YL, Xiong F.
europepmc +1 more source
[Progress in molecular mechanisms and targeted therapies of persistent cancer cells]. [PDF]
Li X, Wang L, Zhao WL.
europepmc +1 more source
[Application of high-throughput drug sensitivity testing in children with relapsed and refractory acute leukemia]. [PDF]
Qi WJ+6 more
europepmc +1 more source
[The guidelines for diagnosis and treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma in China (2025)]. [PDF]
Hematological Oncology Committee of China Anti-Cancer Association+2 more
europepmc +1 more source
[Research progress in systemic lupus erythematosus from 2021 to 2022]. [PDF]
Li YZ, Wu XC.
europepmc +1 more source
[Clinical efficacy analysis of haploidentical high-dose in vitro non-T-cell-depleted peripheral blood hematopoietic stem cell transplantation for the treatment of adult patients with Ph(+) acute lymphoblastic leukemia]. [PDF]
Xu JL+9 more
europepmc +1 more source